Glenmark Life Sciences Ltd

BSE
GLS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Glenmark Life Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
44.92% Gain from 52W Low
6.4
TTM PE Ratio
Below industry Median
22.2
Price to Book Ratio
Above industry Median
4.5
Dividend yield 1yr %
High in industry
2.6
TTM PEG Ratio
PEG TTM is much higher than 1
26.3
RSI
RSI is mid-range
48.2
MFI
MFI is mid-range
65.5

Glenmark Life Sciences Ltd shareholding Pattern

Promoter
82.8%
Foreign Institutions
4.8%
Mutual Funds
1%
Domestic Institutions
1.6%
Public
10.8%
Promoter
82.8%
Foreign Institutions
5%
Mutual Funds
0.9%
Domestic Institutions
1.4%
Public
10.7%
Promoter
82.8%
Foreign Institutions
4.6%
Mutual Funds
0.6%
Domestic Institutions
0.7%
Public
11.8%
Promoter
82.8%
Foreign Institutions
4.4%
Mutual Funds
0.4%
Domestic Institutions
0.6%
Public
12.1%
Promoter
82.8%
Foreign Institutions
3.3%
Mutual Funds
0.5%
Domestic Institutions
0.6%
Public
13.3%
Promoter
82.8%
Foreign Institutions
3.3%
Public
13.9%

Glenmark Life Sciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
9
5Day EMA
857.00
10Day EMA
864.20
12Day EMA
865.00
20Day EMA
863.90
26Day EMA
861.40
50Day EMA
849.40
100Day EMA
822.90
200Day EMA
765.80
5Day SMA
853.30
10Day SMA
878.80
20Day SMA
863.90
30Day SMA
861.30
50Day SMA
848.10
100Day SMA
825.20
150Day SMA
801.90
200Day SMA
758.30
Delivery & Volume
Resistance & Support
850.85
Pivot
Resistance
First Resistance
860.70
Second Resistance
866.30
Third Resistance
876.15
Support
First Support
845.25
Second support
835.40
Third Support
829.80
Relative Strength Index
48.22
Money Flow Index
65.53
MACD
3.66
MACD Signal
8.94
Average True Range
29.90
Average Directional Index
20.55
Rate of Change (21)
0.21
Rate of Change (125)
15.62

Glenmark Life Sciences Ltd Company background

Founded in: 2011
Managing director: Yasir Yusufali Rawjee
The company was incorporated as Zorg Laboratories Private Limited, a private limited company under the Companies Act, 1956 on 23 June 2011 at Pune and was granted the certificate of incorporation by the Registrar of Companies, Maharashtra at Pune (RoC). Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited pursuant to a special resolution passed by the shareholders of the Company on 25 July 2018 and a fresh certificate of incorporation dated 10 August 2018 was issued by the RoC. A shareholders resolution was passed on 13 August 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited. The Company acquired API division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January 2019.The company is primarily engaged in the business of development,manufacture and marketing of Active Pharmaceutical Ingredients(APIs). The companys RD facilities are located at Mahape,Ankleshwar and Dahej and manufacturing facilities are located at Ankleshwar,Dahej,Mohol and Kurkumbh.During the year 201819, the company allotted 4,50,090 Equity Shares of Rs. 10/ each on the conversion of loan given to Director. During the year, 15,00,000 equity shares of the face value of Rs. 10 each fully paidup issued to Glenmark Pharmaceuticals Limited (Parent Company) pursuant to the Preferential Allotment. Subsequent to the quarter ended 30 June 2021, the company has completed the IPO of 21,022,222 equity shares comprising a fresh issue of 14,722,222 equity shares and offer for sale of 6,300,000 equity shares of face value of Rs 2 each at premium of Rs 718 per share aggregating to Rs 15,136 million. Pursuant to the IPO, the equity shares of the Company are listed on BSE Limited and National Stock Exchange of India Limited with effect from 06 August 2021.The Gross Debt comprising of Outstanding Purchase Consideration payable to the Parent Company was Rs 8,008.3 million as on 09 July 2021.The Company has repaid the whole of this remaining outstanding purchase consideration from the proceeds of the Fresh Issue pursuant to the IPO.
Read More

Glenmark Life Sciences Ltd FAQs

The past 1-year return of Glenmark Life Sciences Ltd [GLS] share was 41.98. The Glenmark Life Sciences Ltd [GLS] share hit a 1-year low of Rs. 584.45 and a 1-year high of Rs. 970.

The Mutual Fund Shareholding was 1.01% at the end of .

You can easily buy Glenmark Life Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -